Kinetic Chain Activation Technique on foot pressure, pain and its effects on daily activities - A Randomized Controlled Trial

Completed

• Conditions: plantar fasciitis

• Registration Number: CTRI/2022/09/045717
• Lead Sponsor: KAHER institute of physiotherapy

Brief Summary

Participant selection will be done as per the Inclusion and exclusion criteria. The purpose and

procedure of the study will be explained to the participants. All the covid-19 precautionary measures

according to ICMR will be taken. A brief demographic data and baseline outcome measures will be

obtained from the

participants. Participants will be equally divided into two groups using chit method Group therapy sessions will be carried out in the respective colleges of KAHER institute. Group A will be given Kinetic chain activation technique and Group B will be given conventional treatment

Detailed Description

Not available

Study Timeline

• Study Start: 2022-09-21
• Last Update Posted: 2023-09-04
• Study Completion: 2023-10-03

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• All genders aged between 19 to 65 years diagnosed with plantar fasciitis.
• Individuals who have positive windlass test Individuals who present with unilateral or bilateral pain during the initial steps in the morning Individuals whose VAS score is ≥ 3.

Exclusion Criteria

Lower limb fracture in last 6 months Corticosteroid injection in the heel in past 3 months Plantar fibromatosis (or) ledderhose disease Sprain and strains in ankle-foot region Foot surgeries in last 6 months Impaired sensation in lower extremities Ankylosis or arthritis of ankle Calcaneal spur Congenital foot deformities Lower limb deformities OA with varus or valgus deformities.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pressure algometer	at base line i.e is on day 0 and 14 day after 2 weeks
Foot function index	at base line i.e is on day 0 and 14 day after 2 weeks
Chippaux – smirak index with Harris mat foot imprinter	at base line i.e is on day 0 and 14 day after 2 weeks

Secondary Outcome Measures

Name	Time	Method
not applicable	not applicable

Trial Locations

Locations (1)

KLE hospital; 🇮🇳 Belgaum, KARNATAKA, India

KLE hospital

🇮🇳Belgaum, KARNATAKA, India

Chandana patil

Principal investigator

8197807656

chandupatil.csp@gmail.com